micafungin sodium · Baxter Hlthcare Corp · NDA 216142
Micafungin In Sodium Chloride 0.9%
Earliest generic entry, as listed · earliest of 3 marketed strengths
15 Dec 2037
Blocked by patent: US 12403173.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 12403173 | drug product · sets the listed date | 15 Dec 2037 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 3
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 216142 · 001 · RLD | solution, intravenous | EQ 50MG BASE/50ML (EQ 1MG BASE/ML) | 15 Dec 2037 |
| 216142 · 002 · RLD | solution, intravenous | EQ 100MG BASE/100ML (EQ 1MG BASE/ML) | 15 Dec 2037 |
| 216142 · 003 · RLD | solution, intravenous | EQ 150MG BASE/150ML (EQ 1MG BASE/ML) | 15 Dec 2037 |